Infectious Disease Alert – March 1, 2024
March 1, 2024
View Issues
-
Doxycycline Reduces the Risk of C. difficile Infection in Patients Treated for Community-Acquired Pneumonia
In a retrospective study from the VA, doxycycline was associated with a lower risk of C. difficile infection compared to azithromycin in hospitalized patients with community-acquired pneumonia.
-
Updated Recommendations for Pediatric Immunization
Just-released 2024 pediatric and adolescent immunization recommendations and schedules guide current vaccinations. Specifically, there are new recommendations for protection against COVID-19, dengue, mpox, pneumococcus, polio, and respiratory syncytial virus.
-
Early Transition to Oral Antibiotic Therapy in Low-Risk Patients with Staphylococcus aureus Bloodstream Infection
Completion of therapy with oral antibiotics was shown to be non-inferior to continued intravenous therapy in patients considered to have low-risk Staphylococcus aureus bacteremia.
-
Tularemia in the United States
Tularemia is seen in all U.S. states other than Hawaii. Therapy with tetracyclines, aminoglycosides, and fluoroquinolones is effective.
-
Infectious Disease Alert Updates
Influenza Vaccine Less Effective in 2021-2022 Season; Every Hospital Needs an ID Doc